Article Type
Changed
Display Headline
Managing Melanoma In Situ
With its increasing incidence and being a precursor to invasive melanoma, the treatment of MIS, in particular lentigo maligna, is a topic of increasingly significant interest. The ideal management of MIS is openly debated.

Kristen L. Toren, MD, and Eric C. Parlette, MD

Melanoma is a highly aggressive skin cancer with an increasing incidence. Melanoma in situ is an early, non-invasive form in which the tumor is confined to the epidermis. Treatment of melanoma in situ is challenging due to the frequent subclinical microscopic spread and to the presentation on the head and neck in cosmetically sensitive areas with chronic sun damage. Optimizing tumor eradication is imperative to reduce the potential progression into invasive disease and metastasis, all while maintaining cosmesis. Multiple treatment regimens have been implemented for managing difficult melanoma in situ tumors. We provide a thorough review of surgical, and non-surgical, management of melanoma in situ which can pose therapeutic dilemmas due to size, anatomic location, and subclinical spread.

*For a PDF of the full article, click on the link to the left of this introduction.

Article PDF
Author and Disclosure Information

Publications
Topics
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF
With its increasing incidence and being a precursor to invasive melanoma, the treatment of MIS, in particular lentigo maligna, is a topic of increasingly significant interest. The ideal management of MIS is openly debated.
With its increasing incidence and being a precursor to invasive melanoma, the treatment of MIS, in particular lentigo maligna, is a topic of increasingly significant interest. The ideal management of MIS is openly debated.

Kristen L. Toren, MD, and Eric C. Parlette, MD

Melanoma is a highly aggressive skin cancer with an increasing incidence. Melanoma in situ is an early, non-invasive form in which the tumor is confined to the epidermis. Treatment of melanoma in situ is challenging due to the frequent subclinical microscopic spread and to the presentation on the head and neck in cosmetically sensitive areas with chronic sun damage. Optimizing tumor eradication is imperative to reduce the potential progression into invasive disease and metastasis, all while maintaining cosmesis. Multiple treatment regimens have been implemented for managing difficult melanoma in situ tumors. We provide a thorough review of surgical, and non-surgical, management of melanoma in situ which can pose therapeutic dilemmas due to size, anatomic location, and subclinical spread.

*For a PDF of the full article, click on the link to the left of this introduction.

Kristen L. Toren, MD, and Eric C. Parlette, MD

Melanoma is a highly aggressive skin cancer with an increasing incidence. Melanoma in situ is an early, non-invasive form in which the tumor is confined to the epidermis. Treatment of melanoma in situ is challenging due to the frequent subclinical microscopic spread and to the presentation on the head and neck in cosmetically sensitive areas with chronic sun damage. Optimizing tumor eradication is imperative to reduce the potential progression into invasive disease and metastasis, all while maintaining cosmesis. Multiple treatment regimens have been implemented for managing difficult melanoma in situ tumors. We provide a thorough review of surgical, and non-surgical, management of melanoma in situ which can pose therapeutic dilemmas due to size, anatomic location, and subclinical spread.

*For a PDF of the full article, click on the link to the left of this introduction.

Publications
Publications
Topics
Article Type
Display Headline
Managing Melanoma In Situ
Display Headline
Managing Melanoma In Situ
Article Source

PURLs Copyright

Inside the Article

Article PDF Media